Connect with us

National

Researchers say newly identified antibodies can neutralise SARS-CoV-2 – Pharmaceutical Technology

Researchers at Columbia University Irving Medical Center have identified neutralising antibodies, isolated from Covid-19 patients, against SARS-CoV-2.

Published

on

post featured image

Cryo-EM reconstructions show how two different antibodies (blue) bind to the spike protein of the SARS-CoV-2 virus. Credit: David Ho / Columbia University Irving Medical Center.
Sign up here for GlobalData’s free bi-weekly Covid-19 report on the latest information your industry needs to know.
Researchers at Columbia University Irving Medical Center in the US have identified neutralising antibodies, isolated from Covid-19 patients, against the SARS-CoV-2 virus.
These antibodies are said to be…

Click here to view the original article.